- November 8, 2018
12:00 PM - 1:00 PM ET
Prior FDA Grand Rounds presentation
Applied Technology Center
FDA's Office of Regulatory Affairs
Pacific Northwest Laboratory
About the Presentation
Sensory analysis is performed in FDA testing laboratories to determine the decomposition status of seafood samples. Current methodology to complement this testing with chemical analysis (e.g., histamine) is not always directly comparable to sensory testing.
The presentation will discuss a novel method that FDA is exploring with untargeted analysis and a statistical model driven by sensory results via a script written in the R programming language. This enables generation of data that are directly comparable to commonly used sensory scoring techniques.
The method was applied to six species of salmon, across a wide range of decomposition conditions. Accuracy and reproducibility of the method in comparison with sensory results were demonstrated, and show promising results. Since it generates data which are comparable to sensory analysis, it provides a potentially useful companion to that work. Implementation of this technique stands to open an additional avenue for this type of analysis, aiding the agency’s public health mission with increased coverage of this issue.
About the Presenter
Randy Self is a research chemist with FDA’s Applied Technology Center in the Pacific Northwest Laboratory, where he conducts research on method development for food safety applications. His work focuses primarily on development of novel high-resolution mass spectrometry techniques. Randy has been with FDA since 2001, serving as a regulatory chemist at the Pacific Northwest Laboratory before joining the Agency's Applied Technology Center.